Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2524-2531
Published online before print September 20, 2007, doi: 10.1161/ATVBAHA.107.151167
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/12/2524    most recent
ATVBAHA.107.151167v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erusalimsky, J. D.
Right arrow Articles by Moncada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erusalimsky, J. D.
Right arrow Articles by Moncada, S.
Related Collections
Right arrow Nitric Oxide Redux
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2524.)
© 2007 American Heart Association, Inc.


Brief Reviews

Nitric Oxide and Mitochondrial Signaling

From Physiology to Pathophysiology

Jorge D. Erusalimsky; Salvador Moncada

From The Wolfson Institute for Biomedical Research (J.D.E., S.M.), University College London, and the Cardiff School of Health Sciences (J.D.E.), University of Wales Institute Cardiff, UK.

Correspondence to Jorge D. Erusalimsky, Cardiff School of Health Sciences, University of Wales Institute Cardiff, Western Avenue, Cardiff, CF5 2YB, UK. E-mail jderusalimsky{at}uwic.oc.uk; or Salvador Moncada, The Wolfson Institute for Biomedical Research, University College London, Gower Street, London, WC1E 6BT, UK. E-mail s.moncada@ucl.oc.uk

Series Editor: Joseph Loscalzo
Nitric Oxide Redux
ATVB In Focus

Previous Brief Reviews in this Series:

•Kim-Shapiro DB, Schechter AN, Gladwin MT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. 2006;26:697.
•Handy DE, Loscalzo J. Nitric oxide and posttranslational modification of the vascular proteome. 2006;26:1207.
•Gotoh T, Mori Masataka. Nitric oxide and endoplasmic reticulum stress. 2006;26:1439–1446.
•Coggins MP and Bloch KD. Nitric oxide in the pulmonary vasculature. 2007;27:1877–1885.

Nitric oxide (NO) has been known for many years to bind to cytochrome C oxidase, the terminal acceptor in the mitochondrial electron transport chain, in competition with oxygen. This interaction may be significant in vivo and explain some of the biological actions of NO. In this article we review the evidence showing that binding of NO to cytochrome C oxidase elicits intracellular signaling events, including the diversion of oxygen to nonrespiratory substrates and the generation of reactive oxygen species. We discuss findings indicating that these NO-elicited events act as triggers by which mitochondria modulate signal transduction cascades involved in the induction of cellular defense mechanisms and adaptive responses. We also discuss instances in which the effects of NO on the electron transport chain might lead to mitochondrial dysfunction and pathology.

This review summarizes the evidence showing that binding of NO to cytochrome C oxidase elicits signaling events by which mitochondria modulate cellular defense mechanisms and adaptive responses. We also discuss instances in which the effects of NO on the electron transport chain might lead to mitochondrial dysfunction and pathology.


Key Words: nitric oxide • mitochondria • reactive oxygen species • signal transduction • cytoprotection




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Aamand, T. Dalsgaard, F. B. Jensen, U. Simonsen, A. Roepstorff, and A. Fago
Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2068 - H2074.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. J. James, S. Rose, S. Melnyk, S. Jernigan, S. Blossom, O. Pavliv, and D. W. Gaylor
Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism
FASEB J, August 1, 2009; 23(8): 2374 - 2383.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
M. Misfeldt, A. Fago, and H. Gesser
Nitric oxide increases myocardial efficiency in the hypoxia-tolerant turtle Trachemys scripta
J. Exp. Biol., April 1, 2009; 212(7): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. D. Erusalimsky and C. Skene
Mechanisms of endothelial senescence
Exp Physiol, March 1, 2009; 94(3): 299 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Erusalimsky
Vascular endothelial senescence: from mechanisms to pathophysiology
J Appl Physiol, January 1, 2009; 106(1): 326 - 332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Feelisch, B. O. Fernandez, N. S. Bryan, M. F. Garcia-Saura, S. Bauer, D. R. Whitlock, P. C. Ford, D. R. Janero, J. Rodriguez, and H. Ashrafian
Tissue Processing of Nitrite in Hypoxia: AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND -SCAVENGING SYSTEMS
J. Biol. Chem., December 5, 2008; 283(49): 33927 - 33934.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
J. Van Blerkom, P. Davis, and V. Thalhammer
Regulation of mitochondrial polarity in mouse and human oocytes: the influence of cumulus derived nitric oxide
Mol. Hum. Reprod., August 1, 2008; 14(8): 431 - 444.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Schleicher and W. C. Sessa
Are the Mechanisms for NO-Dependent Vascular Remodeling Different From Vasorelaxation In Vivo?
Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1207 - 1208.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Lerner-Marmarosh, T. Miralem, P. E. M. Gibbs, and M. D. Maines
Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling
PNAS, May 13, 2008; 105(19): 6870 - 6875.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Ruttimann
Macrophages and nitric oxide: A deadly combination
J. Exp. Med., December 24, 2007; 204(13): 3057 - 3057.
[Abstract] [Full Text] [PDF]